Cowen Group

Cowen Group

Cowen Group

Xconomy

Bristol Myers to Buy MyoKardia, FDA-Ready Heart Disease Drug for $13.1B

Xconomy

Perceptive Advisors’ LianBio Inks Deals With BridgeBio, MyoKardia

$10,000,000 Venture capital (Series A)
neurons.AI

Kyber Data Science Bags $10M in Series A Round of Financing

Forbes Tech

Teladoc To Buy Livongo Health In $18.5 Billion Virtual Care Mega-Deal

FinSMEs , neurons.AI

Kyber Data Science Raises $10M in Series A Financing

neurons.AI

Kyber Data Science Raises $10 Million In Series A

neurons.AI

Kyber Data Science Announces $10 Million Series A Financing Round

neurons.AI

Kyber Data Science Announces $10 Million Series A Financing Round

Pulse 2.0

Livongo Health Stock (LVGO): Should I Buy It Now?

Xconomy

MyoKardia’s Heart Drug Shines in Phase 3, FDA Filing Planned for 2021

the home of AI info

Minerva Neurosciences Inc. (NERV)'s Financial Results Comparing With MyoKardia Inc. (NASDAQ ...

the home of AI info

Minerva Neurosciences Inc. (NERV)'s Financial Results Comparing With MyoKardia Inc. (NASDAQ ...

oliverwyman

Q&A: Livongo on Breaking into a New Digital Health Market

MedCity News

Livongo playing a critical role in helping employers disrupt healthcare

Xconomy

MyoKardia Goes Solo as Sanofi Ends Precision Heart Drug Deal

FinSMEs

Orchard Therapeutics Prices Initial Public Offering

Stock markets Health Costs
$200,000,000 IPO
PE HUB , FinSMEs

VC-backed Orchard Therapeutics goes public

Stock markets
TechCrunch

Livongo Health expands under new offering with Abbott Labs

Health Cloud
$150,000,000 Venture capital (Series C)
FinSMEs , Xconomy

Orchard Therapeutics Raises $150M in Series C Financing

Funding Health
$75,000,000 IPO
PE HUB

VC-backed Kezar Life Sciences unveils IPO

Stock markets Health